N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder

Bipolar Disorders

Volumn 7, Issue 6, 2005, Pages 589-597

  Gallelli, Kim A ^a   Wagner, Christopher M ^a   Karchemskiy, Asya ^a   Howe, Meghan ^a   Spielman, Daniel ^a   Reiss, Allan ^a   Chang, Kiki D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Bipolar disorder; Children; Magnetic resonance spectroscopy; N acetylaspartate; Offspring; Prodromal

Indexed keywords

CHOLINE; INOSITOL; LITHIUM; MOOD STABILIZER; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; OPPOSITIONAL DEFIANT DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGENY; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ASPARTIC ACID; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; CREATINE; DEMOGRAPHY; FAMILY HEALTH; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; PROTONS; RISK FACTORS;

EID: 29244453643     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00266.x     Document Type: Article

References (34)

1. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatinine and choline. NMR Biomed 1991; 4: 47-52.
2. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10: 191-247.
3. Cecil KM, DelBello MP, Sellars MC, Strakowski SM. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adol Psychopharm 2003; 4: 545-555.
4. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475-481.
5. Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 2003; 53: 1059-1065.
6. Pardo JV, Pardo PJ, Raichle ME. Neural correlates of self-induced dysphoria. Am J Psychiatry 1993; 150: 713-719.
7. MacDonald AW III, Cohen JD, Stenger VA, Carter CS. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000; 288: 1835-1838.
8. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998; 95: 13290-13295.
9. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord 2002; 836: 253-268.
10. Yurgelon-Todd DA, Gruber SA, Kanayam G, Kilgore WD, Baird AD, Young AD. FMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2000; 2: 237-248.
11. Chang K, Steiner H, Dienes K, Adleman N, Ketter T. Bipolar offspring: a window into bipolar disorder evolution. Biol Psychiatry 2003; 53: 945-951.
12. DelBello MP, Geller B. Review of studies of child and adolescent offspring of bipolar parents. Bipolar Disord 2001; 3: 325-334.
13. Carlson GA, Wintraub S. Childhood behavior problems and bipolar disorder-relationship or coincidence? J Affect Disord 1993; 28: 143-153.
14. Wozniak J et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995; 34: 867-876.
15. Geller B, Zimerman B, Williams M et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 2001; 40: 450-455.
16. Geller BG, Williams M, Zimerman B, Frazier J. WASH-U-KSADS (Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia). St Louis, MO: Washington University, 1996.
17. Kaufman J, Birmaher B, Brent D et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-988.
18. Geller BG, Warner K, Williams M, Zimerman B. Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL AND TRF. J Affect Disord 1998; 51: 93-100.
19. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute, 1995.
20. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
21. Poznanski EO, Freeman LN, Mokros HB. Children's depressive rating scale-revised. Pyschopharmacol Bull 1985; 21: 979-989.
22. Fristad MA, Weller EB, Weller RA. The mania rating scale: can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 1992; 31: 252-257.
23. Fristad MA, Weller RA, Weller EB. The Mania Rating Scale (MRS): further reliability and validity studies with children. Ann Clin Psychiatry 1995; 7: 127-132.
24. Andreasen NC, Endicott J, Spitzer RL, Winokur G. The family history method using criteria. reliability and validity. Arch Gen Psychiatry 1977; 34: 1229-1235.
25. Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull 1985; 21: 995-998.
26. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry 2004; 61: 781-792.
27. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997; 9: 471-481.
28. Blumberg HP, Charney DS, Krystal JH. Frontotemporal neural. systems in bipolar disorder. Semin Clin Neuropsychiatry 2002; 7: 243-254.
29. Horska A, Kaufmann WE, Brant LJ, Naiju S, Harris JC, Parker PB. In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 2002; 15: 137-143.
30. Moore GJ, Bebchuk JM, Hasanat K et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000; 48: 1-8.
31. Sassi RB, Nicoletti M, Brambilla P et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 2002; 329: 243-245.
32. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004; 29: 1918-1924.
33. Narayana PA, Wolinsky JS, Rao SB, He R, Mehta M; PROMise Trial MRSI Group. Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis. Mult Scler 2004; 10: S73-S79.
34. Bertolino A, Frye M, Callicott JH et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study of proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003; 53: 906-913.